Curis Lifesciences Board of Directors
Get the latest insights into the leadership at Curis Lifesciences. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Dharmesh Dasharathbhai Patel | Chairman & Managing Director |
| Mr. Piyush Gordhanbhai Antala | Whole Time Director |
| Mr. Jaimik Mansukhlal Patel | Whole Time Director |
| Mr. Siddhant Jayantibhai Pawasia | Non Executive Director |
| Mr. Chand Rameshbhai Kanabar | Independent Director |
| Mr. Grishma A Shewale | Independent Director |
| Mr. Dhruvi Shyam Kapadia | Independent Director |
Curis Lifesciences Share price
CURIS
99
1.00 (1.02%)Last updated on 20 Feb, 2026 | 14:50 IST
BUYSELL
Today's High
100.00
Today's Low
99.00
52 Week Low
96.95
52 Week High
147.90
Free Demat with Zero AMC*
Curis Lifesciences FAQs
The board at Curis Lifesciences consists of experienced professionals, including Mr. Dharmesh Dasharathbhai Patel , Mr. Piyush Gordhanbhai Antala , and others, overseeing the company’s strategic and corporate governance.
Directors at Curis Lifesciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Dharmesh Dasharathbhai Patel is the current chairman at Curis Lifesciences.
Executive directors at Curis Lifesciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Curis Lifesciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Curis Lifesciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
